Welcome to our dedicated page for Axon Enterprise SEC filings (Ticker: AXON), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Axon Enterprise, Inc. filings document operating results and corporate actions for a public safety technology company with Software & Services and Connected Devices activities. Form 8-K reports include shareholder letters on financial results and outlooks, product demand across TASER devices, Axon Body cameras, Axon Evidence, AI products, counter-drone offerings and real-time operations, as well as material-event disclosures tied to capital structure.
Proxy materials cover board composition, shareholder meeting matters, executive compensation and equity awards. Other 8-K and 8-K/A filings record director election updates and the redemption and settlement of 0.50% convertible senior notes due 2027, including the disclosure that no convertible notes remained outstanding after the redemptions and conversions.
AXON notice of proposed sale under Form 144 filed through Morgan Stanley Smith Barney LLC. The filing lists 1,242 common stock units tied to Restricted Stock Units with an entry date of 05/31/2026 and shows an administrative record date of 06/04/2026. The filing also records a prior 10b5-1 sale by Cameron J. Brooks on 03/09/2026 showing 1,221 common units and a value figure of $690,487.71. This is a routine Form 144 notice of an intended resale by an affiliate; cash‑flow treatment and final sale mechanics are not included in the excerpt.
AXON filed a Form 144 reporting proposed sales of Common stock under compensation arrangements. The notice lists 915 shares tied to Performance Stock Units with a 12/01/2025 reference and 639 shares tied to Restricted Stock Vesting Under a Registered Plan with a 05/31/2026 reference. The brokerage firm listed is Morgan Stanley Smith Barney LLC and the market is identified as NASDAQ.
AXON submitted a notice under Section 144 for the proposed sale of 20,000 common shares. The filing lists the method as Option Exercise with a related date of 11/15/2021. The filing also discloses that Patrick W. Smith sold 10,000 common shares on 03/09/2026 for $5,602,394.00.
AXON ENTERPRISE, INC. Chief Accounting Officer Jennifer H. Mak reported two transactions in common stock tied to tax withholding. On June 1, 2026, a total of about 2,223.9 shares were disposed of to cover tax liabilities from the vesting of restricted stock units under Axon’s equity plans. These are administrative, non–open-market dispositions and do not represent discretionary share sales.
AXON ENTERPRISE, INC. Chief Product & Technology Officer Jeffrey C. Kunins reported a routine tax-related share withholding tied to vesting of performance-based restricted stock units. On June 1, 2026, 8,113.183 shares of common stock at $476.88 per share were disposed of to settle his tax liability from the vesting of the third tranche of RSUs granted under the Axon Enterprise, Inc. 2024 eXponential Stock Plan.
Following this tax-withholding disposition, Kunins directly held 59,696.817 shares of Axon common stock. Separately, he indirectly owned 86,268 shares through an LLC of which he is the sole member. The Form 4 does not show any open-market purchases or sales, only the tax withholding and updated holdings.
AXON ENTERPRISE, INC. COO & CFO Brittany Bagley reported an open-market sale of 5,969 shares of common stock on June 2, 2026 at $485.00 per share. After this transaction, she directly owned 77,084.479 shares of Axon common stock.
On June 1, 2026, 16,181.521 shares were disposed of at $476.88 per share to cover her tax liability from the vesting of the third tranche of restricted stock units granted under Axon’s 2024 eXponential Stock Plan, which is a tax-withholding event rather than an open-market sale.
Axon Enterprise president Joshua Isner reported a tax-withholding disposition of common stock tied to vesting restricted stock units. On this event, 32,796.371 shares of common stock were withheld at $476.8800 per share to settle his tax liability from the vesting of the third tranche of RSUs.
These RSUs were granted under the Axon Enterprise, Inc. 2024 eXponential Stock Plan, after performance conditions were certified by the company’s Compensation Committee on November 13, 2025. Following the tax withholding, Isner directly holds 182,124.629 shares of Axon common stock. This disposition reflects tax settlement and is not an open-market trade.
AXON ENTERPRISE, INC. executive Elizabeth Reid Coughlin, the company’s Chief Human Officer, reported two tax-withholding dispositions of common stock tied to restricted stock unit vesting. A total of 3,401.209 shares were withheld to cover her tax liabilities upon vesting, including performance-based awards under Axon’s 2024 eXponential Stock Plan. These were not open-market sales, but shares retained by the issuer for taxes. Following these dispositions, she directly holds 38,499.346 shares of Axon common stock.
AXON ENTERPRISE, INC. chief revenue officer Cameron Brooks reported a routine share disposition tied to taxes rather than a market trade. On June 1, 2026, 743.757 shares of common stock were withheld at $448.72 per share to cover tax liability from vesting restricted stock units. Following this tax-withholding event, Brooks directly holds 50,951.933 shares of Axon common stock.
Axon Enterprise Chief Legal Officer Isaiah Fields reported routine share dispositions related to tax withholding. On June 1, 2026, a total of 5,257.268 shares of common stock were disposed of at prices of $476.88 and $448.72 per share to settle tax liabilities from the vesting of restricted stock units, including awards under the Axon Enterprise, Inc. 2024 eXponential Stock Plan.